Histogenics Announces $30.0MM Private Placement

Histogenics entered into an agreement to raise ~US $30.0MM in a private placement comprising common stock, Series A Convertible Preferred Stock and exercisable warrants. The placement is led by new investors, with participation from certain existing investors.

Net proceeds will support the development of NeoCart® novel cartilage repair...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us